A series of fluorinated tripodal tris-thioureas function as highly active anion transporters across lipid bilayers and cell membranes. Here, we investigate their mechanism of action using anion transport assays in cells and synthetic vesicles and molecular modelling of transporter-lipid interactions. When compared with non-fluorinated analogues, fluorinated compounds demonstrate a different mechanism of membrane transport because the free transporter cannot effectively diffuse through the membrane. As a result, in H + /Cl À cotransport assays, fluorinated transporters require the presence of oleic acid to form anionic oleate complexes for recycling of the transporter, whereas non-fluorinated analogues readily diffuse through the membrane as free transporters and show synergistic transport with the proton transporter gramicidin. Molecular dynamics simulations revealed markedly stronger transporter-lipid interactions for fluorinated compounds compared with non-fluorinated analogues and hence, higher energy barriers for fluorinated compounds to cross the membrane as free transporters. With use of appropriate proton transporters to ensure measurement of the correct rate-limiting steps, the transport rates determined in synthetic vesicle assays show excellent agreement with the anion transport rates determined in cellbased assays. We conclude that integration of computational and experimental methods provides a strategy to optimise transmembrane anion transporter design for biomedical applications.
Introduction
The design, synthesis and investigation of small synthetic transmembrane anion transporters (anionophores) is an important focus of supramolecular chemistry research due to the potential biomedical application of these compounds as research tools and innovative therapies for genetic diseases caused by loss of anion transport.
1 Numerous classes of anionophores have now been reported 2 and structure-activity studies conducted to optimise transporter design. These have included analysis of substituent effects, 3 dening the principle of lipophilic balance, 4 tuning the length of alkyl tails to enhance transporter activity 5 and anion encapsulation to confer Cl À selectivity.
6
Fluorination of therapeutically active compounds is a commonly used strategy in medicinal chemistry to modulate lipophilicity, acidity, conformation and pharmacokinetic properties or to tune reactivity. 7 The ability to tune properties such as lipophilicity with small structural modications is desirable in transmembrane transport, given the well-established requirement to optimise the log P of a transporter scaffold to balance its affinity for different regions of the membrane.
8
In the development of highly active anion transporters, addition of triuoromethyl or uorine substituents has proven to be an effective strategy. This has been attributed to a combination of increased lipophilicity and anion binding strength.
9
For example, a CF 3 -containing o-phenylenediamine-bisurea was developed as a small-molecule bicarbonate transporter that outperforms the natural anionophore prodigiosin in vesicle tests. 10 It has also been reported that replacement of a linear hydrocarbon chain by a uorocarbon chain led to increased Cl À /NO 3 À exchange efficacy of the monoacylglycerol class of transporters. 11 To our knowledge however, there has been little systematic study of the effects of uoroalkyl substituents.
Therefore, the precise effects of alkyl uorination on anionophore mechanism and interaction with the lipid bilayer are currently unknown.
Due to the highly polarised nature of the C-F bond, 12 which stems from the high electronegativity of uorine, peruorinated compounds are strongly non-polarisable. 13 Thus, polyuorinated compounds offer unique amphiphobic properties, such as insolubility in both polar and organic solvents, which has been exploited in the separation of complex reaction mixtures.
14 With new tools available to elucidate anionophore mechanism of action 6 and the ability to monitor anion transport by anionophores in living cells, 15 we investigated the effects of alkyl uorination on anion transport by synthetic anionophores to determine the physical effects of uorination on the transport process and activity. To contextualise these observations, a comprehensive molecular dynamics study of the behaviour of the compounds within a model POPC bilayer was also undertaken to identify the structural and energetic origins of the trends observed.
For this study, a systematic series of alkyl and uorous tristhiourea anion transporters 1-8 (Fig. 1 ) was designed. Additionally, compounds 9 and 10 were also synthesised with a single terminal CF 3 group to determine whether the number of C-F bonds mediate any observed effects (Fig. 1) .
Results and discussion

Synthesis and characterisation
Compounds 1-4 were synthesised in a single step from commercially available tris-(2-aminoethyl)amine and the appropriate isothiocyanates; compounds 3 and 4 have been previously reported. 6, 16 Compounds 5-10 were synthesised from the appropriate commercially available uorous alkyl amine and the tris-(isothiocyanatoethyl)amine intermediate 11, prepared as per the literature procedure (Fig. 1) . 17 As part of this work, an X-ray crystal structure of 3 was obtained, showing Cl À held by six$NH/Cl À hydrogen bonds (Fig. 2) . Full experimental details and characterisation data are available in Section 2 of ESI. † The lipophilicity of compounds 1-10 was evaluated by determining the experimental retention factor (k 0 ) calculated from the measured retention of the compounds on a C 18 RP-HPLC column aer isocratic elution with 50% CH 3 CN/H 2 O. Under these conditions, log(k 0 ) is proportional to log P, 18 and these values are tabulated in Table 1 . Peruorination of the alkyl chains resulted in a large increase in lipophilicity (e.g. increase of 1.06 units in log(k 0 ) from compound 3 (butyl) to 7
(peruorinated butyl)). By contrast, the increase in lipophilicity on the introduction of a single CF 3 substitution was very modest (increase of 0.11 units between 3 and 10), as has been noted in previous studies. 
Transport in synthetic vesicles
To measure Cl À transport by compounds 1-10, we used a pHdischarge vesicle-based assay (Fig. 3) . POPC vesicles loaded with the pH-sensitive dye 8-hydroxypyrene-1,3,6-trisulfonic acid (HPTS) were suspended in a solution of N-methyl-D-glucamine (NMDG) chloride, buffered to pH 7.0 with HEPES (10 mM). The test compound was added externally as a solution in DMSO, before the transport assay was commenced by the external addition of the free base NMDG to raise the external pH to 8.0. Anionophores were added at 0.01 mol% loading with respect to lipid.
In this assay, anionophores dissipate the pH gradient generated by external NMDG addition (Fig. 4) 23 However, the use of both Gr and OA in HPTS assays provided key mechanistic insights that are not accessible using one proton transporter alone, as will be detailed in this section.
We performed the HPTS assay on all anionophores using three conditions: (i) without any proton transporter, (ii) with Gr and (iii) with OA. The initial rates determined for each compound at 0.01 mol% loading under these conditions are plotted in Fig. 5 .
The data demonstrate that uorination of the tripodal thioureas dramatically improved transmembrane Cl À transport.
Except for compound 8 that might be too lipophilic to be effectively delivered into the lipid bilayer, 15 the uorinated compounds are all markedly more active than their nonuorinated analogues and follow the trend of increasing activity with increasing chain length. For example, the most active u-orous compound 6 exhibits an improvement more than an order of magnitude over alkyl analogue 2. Moreover, compounds 9 and 10 exhibited enhanced activity over their alkyl analogues 2 and 3, albeit the effect was not as great as compounds with higher degrees of uorination. These results are further rationalised by our molecular modelling investigations below.
These trends are not simply explained by considering the relationship between the lipophilicity or anion binding ability of the compounds and their transport activity. The data demonstrate no correlation between the initial rate and K a and little evidence of the expected parabolic relationship between Table 1 Selected data for the tris-thiourea series 20 Asymptotic errors all <3%, details in the ESI.
c Electrostatic potential maximum estimated as described below (see the Molecular modelling section). lipophilicity and the transport rate.
8b-d For instance, while compounds 4, 10 and 6 have comparable lipophilicity, the former ones display low initial rates of pH dissipation, while 6 promotes the fastest efflux of Cl À , even in the absence of a proton transporter (Fig. 5) .
On close examination of the HPTS assay data a complex picture emerges with differences in the behaviour of uorinated and non-uorinated analogues. The non-uorinated anionophores 1-4 show enhanced pH gradient dissipation with both Gr and OA ( Fig. 4A and 5 The results also demonstrate that for these anionophores, rate enhancement by OA is not as high as by Gr. We interpret these results to suggest that proton efflux mediated by OA coupled to these anionophores is still potentially ratelimiting and not as kinetically fast as with Gr. In contrast to 1-4, the uorinated compounds 5-10 displayed the surprising behaviour that transmembrane Cl À transport is little affected by Gr, but signicantly enhanced by OA (Fig. 4B, C and 5) . These results suggest a fundamental difference in transport mechanism between the alkyl compounds 1-4 and the uorous analogues 5-10. In the absence of any proton transporters (Fig. 6A) , the anionophore requires six steps to dissipate the pH gradient: (1) the anion transporter (T) binds Cl À on the intra-vesicle side of the membrane; (2) only under the condition that the translocation of the free transporter (step 7) is fast. In the presence of OA (Fig. 6C) , new pathways to complete the overall transport cycle are introduced. The anionophores can perform steps (1)-(3), which can be considered as a partial Cl À transport process (a complete Cl À transport cycle should include step (7)). OA performs partial H + transport by protonation of the oleate ion at the intravesicular side of the membrane to form neutral OA (step 8) and the neutral OA moves to the extravesicular side (step 9) where it deprotonates (step 10). The oleate ion cannot move across the membrane by itself because of the hydrophilicity of the carboxylate head group and therefore a H + transport cycle cannot be completed with OA alone. In the presence of an anionophore, the oleate ion binds the anionophore (step 11) forming a lipophilic anionic complex that moves back to the intravesicular side (step 12) where the complex dissociates (step 13) allowing the anionophore to re-bind Cl À (step 1) and oleate to re-bind H + (step 8) to initiate the next transport cycle. The overall transport cycle results in net ow of H + and Cl À out of vesicles. In this process, there is no requirement for free anionophore to cross the membrane (step 7) because step 12 serves as the alternative process to recycle the free anionophore. As step 7 is required in synergistic transport with Gr, but not OA, the observation for anionophores 5-10 that pH gradient dissipation was enhanced by OA, but not Gr suggests that step 7 is rate-limiting for 5-10.
To summarise, data from the HPTS assays suggest that all the compounds tested mediate steps 1-3 for Cl À transport.
However, for the uorinated compounds 5-10, the free transporter cannot effectively diffuse through the membrane (step 7 prohibited), leading to no synergistic H + /Cl À symport with Gr. 
15
Consistent with our observations using the HPTS assay, uorous compounds demonstrated higher efficacy than their alkyl counterparts (Fig. 7) . Of note, compounds 5 and 6 were more than 40 times more effective than their alkyl counterparts (compounds 1 and 2, respectively). However, further extension of transporter tail length failed to improve anion transport. For example, compound 7 was only 5 times more effective than compound 3, while compound 8 was less effective than compound 4 (Fig. 7) .
To explore anionophore potency in cells, we determined concentration-response relationships for compounds 5-7, 9 and 10 (ESI Fig. S4 .35 †). For compounds 5-7 and 9, uorescence decay exhibited noticeable concentration-dependence, whereas compound 10 did not demonstrate activity until tested at 50 mM. Although YFP uorescence is pH sensitive, 25 the change in uorescence achieved with the tested compounds is too large to be explained by a change in intracellular pH and there was no transmembrane pH gradient in these experiments. Thus, the observed uorescence quenching of YPF resulted from I À entry into the cells instead of a change in intracellular pH. Of note, the most active transporter, compound 6, demonstrates a $50% improvement in transport rate compared with the previously reported best transporter tested in the same assay. 26 We also note that the best correlation between vesicle and cell data was achieved when the fastest rate achieved in any of the proton transporter-assisted assays (with Gr or OA) was used (ESI Fig. S4.36 †) . The YFP-FRT assay measures an exchange process that does not involve free transporter diffusion. As discussed above, in HPTS assays compounds may be limited by different transport processes. It is therefore important to select the conditions that best demonstrate the rate of Cl À transport (steps 1-3). In this way, the correct ratedetermining step is selected to avoid underestimating anionophore activity in the HPTS assays.
Molecular modelling
Using Density Functional Theory (DFT) calculations and Molecular Dynamics (MD), structural and energetic insights into Cl À binding affinity and transmembrane transport by compounds 1-10 were obtained. The electrostatic potential on the molecular surface (V S ) of the binding conformations of transporters 1-10 was computed from the optimised geometries of their Cl À complexes (ESI Section S3.3 †). Table 1 lists values of the electrostatic potential maximum (V S,max ), which are intimately related to anion recognition by anionophores. 8a ESI Fig. S4 .23 † shows their location, the distribution of the electrostatic potential and the optimised structures of the Cl À complexes for compounds 2, 6 and 9. As these transporters have three thiourea binding units synergistically recognising Cl À , the V S,max is located within the binding pocket. Table 1 demonstrates that non-uorinated compounds 1-4 exhibit similar V S,max values, while their uorinated analogues 5-8 have higher V S,max values. Molecules 9 and 10, with three mono-CF 3 substituted chains, have V S,max values slightly lower than 5-8, but higher than 1-4. This comparison shows that within each series of molecules (1-4, 5-8, and 9-10), the tripodal receptors have similar binding affinities for Cl À , which increase in the order 1-4 < 9-10 < 5-8. However, there is no apparent relationship between the V S,max values and the experimental binding constants (Table 1) . For instance, compounds 5 and 7, with similar V S,max values, have the second lowest and highest binding constants of the series. These puzzling results indicate that other factors (e.g. solvent effects and/or conformational changes) play an important role in anion recognition in DMSO. Interestingly, compound 6, which possesses the most acidic thiourea binding units, is the best transmembrane Cl À transporter. However, the V S,max and transport data are not easily related, prompting us to undertake a comprehensive MD investigation with POPC membrane models (ESI Sections S3.3 and S4.4 †).
To evaluate the proposed anion carrier mechanism (step 2, Fig. 6 ), the passive diffusion of the tripodal Cl À complexes in the POPC bilayer was studied with the complexes initially positioned in the bilayer core (scenario A) and simulated for 300 ns (single MD run). In addition, the ability of the tripodal molecules to permeate the water/lipid interface was investigated by positioning their Cl À complexes in the water phase (scenario B) using 200 ns simulations (two independent MD runs). The position and orientation. The position and orientation of the molecules in the bilayer was evaluated using the distances between the tripodal nitrogen (N tren ) atom or the centre of mass dened by the terminal carbon atoms of the three thiourea chains (C ter ) and the closest interface (P int , dened by the centre of mass of the 64 phosphorus atoms in that monolayer, see ESI Fig. S4.24-S4.26 † for  details) .
In scenario A, the anionic tripodal complexes diffuse towards the water/lipid interface, with Cl À sheltered from water molecules by the tripodal conformation of anionophores. Throughout the MD simulations of 1, 4, 7, and 8 the anion is released to the water phase and the transporters form hydrogen bonding interactions with water molecules or phosphate head groups (ESI Fig. S4 .24 †). With increasing uorination and thiourea chain length, the molecules adopt well-dened orientations within the highly-packed phospholipid medium, as observed for 3, 4, 6-10, where the tren moiety is closer to the water phase and the chains are nearly aligned with the phospholipid tails. By contrast, 1, 2 and 5, with their shorter alkyl chains and reduced uorination, adopt random orientations. To simulate transmembrane Cl À transport by 6, the free receptor was dragged at a constant slow velocity (0.5 nsÅ À1 ) from one aqueous phase to the other across the POPC bilayer (ESI Sections S3.3 and S4.4 †). Fig. 9 and Movie S1 † demonstrate that 6 can promote transmembrane Cl À transport as an anion carrier, illustrating step 2 of the transport mechanism (Fig. 6 ). In addition, the slow translocation diffusion velocity allowed the tilting and tumbling of 6$Cl À within the highly packed POPC bilayer, adopting the same preferential orientation near both water/lipid interfaces. The slow permeation of 6$Cl À is accompanied by depression of the entry leaet and many solvating water molecules (ESI Fig. S4 .27 †). The free energy proles associated with the transmembrane translocation of 2, 6, 9 and 8 as free transporters and Cl À complexes were determined from Umbrella Sampling (US) MD simulations by computing the Potential of Mean Force (PMF) using the variational free energy prole (VFEP) method.
27 The starting MD frames for the US windows of the free tripodal transporters were generated by Steered Molecular Dynamics (SMD) simulations where transporters were pulled from the bilayer core to the water phase, while the frames for the charged Cl À complexes were generated from the passive diffusion MD simulations in both scenarios (ESI Section 3.3 †). This approach reduced structural artefacts associated with the diffusion of polar entities across phospholipid bilayers.
28
The PMF of a Cl À complex is intrinsically linked with step 2 of the transport mechanism, while the energy prole of a free transporter characterises step 7 (Fig. 6) . Moreover, the PMF calculations for compounds 2, 6, and 9 energetically assess how uorination affects anionophore-mediated Cl À transport, while the effect of increasing chain length was evaluated with molecules 6 and 8. The PMF proles for Cl À alone and complexed with 2, 6, 8 and 9 show that unassisted Cl À translocation is highly disfavoured (Fig. 10A) . Thus, an anionophore is essential to shuttle Cl À across the bilayer. The PMF minima data further demonstrate that each Cl À complex readily partitions from the water phase to the phospholipid bilayer, but faces an energy barrier (kcal mol À1 ) of 10.6 (2), 9.1 (6), 5.2 (8) and 9.3 (9) to cross the bilayer core towards the opposite leaet (Fig. 10A) . Interestingly, the energy proles of the free transporters follow the same trend of the corresponding Cl À complexes (Fig. 10) . As a result, the PMF minima of the free transporters and of their complexes are linearly correlated (R 2 ¼ 0.94; ESI Fig. S4 .31 †).
The PMF proles indicate that the free transporters surmount higher energy barriers (11.0, 18.8. 24.1 and 13.0 kcal mol À1 for 2, 6, 8 and 9, respectively) than their corresponding complexes (8.2, 15.2, 18.1, 11.9 kcal mol À1 in the same order) to reach the water phase, revealing that the translocation of a complex (step 2, Fig. 6 ) is favoured over the translocation of its free transporter (step 7, Fig. 6B ). They also suggest the existence of stronger anionophore-lipid interactions for uorinated compounds (6, 8 and 9) compared with non-uorinated 2.
Of note, retention times (log(k 0 )) are strongly correlated with the global minima of the individual PMF proles for the free transporters (R 2 ¼ 0.96) and their Cl À complexes (R 2 ¼ 0.93) (Fig. 11, le) . Strong linear relationships were also found when the PMF minima were plotted against the initial rates of Cl À efflux from vesicles (Fig. 11 , centre) or from cells (Fig. 11, right ). These results demonstrate that lipophilicity, determined by degree of uorination and thiourea chain length, plays an important role in the interaction of 2, 9, 6 and 8 with phospholipids and hence, their transport activity. Using Molecular Mechanics (MM), the interaction energies between transporters and POPC lipids were calculated at the positions determined by each PMF prole global minimum, where the compounds adopt a well-dened orientation within the highly-packed lipid medium (ESI Section 3.3.3 †). The interaction energies are composed of electrostatic and van der Waals contributions with the latter being the main contributor to the total MM interaction energy (Table S4 .3 †). This reveals that transport activity is strongly dependent on interactions between anionophores and phospholipids. Consistent with this idea, for free transporters there is a direct relationship between van der Waals contributions and the global minima in the individual free energy proles (R 2 ¼ 0.90; Fig. S4 .32 †).
Because OA markedly enhanced anion transport by uori-nated transporters (e.g. 6) (Fig. 5) , the interaction of 6$OA À with a POPC bilayer was investigated by US MD simulations with the reconstruction of the corresponding PMF (ESI Section 4.4.1 †). The orientation of the long 6$OA À alkyl chain relatively to the membrane was assessed by monitoring the position of the terminal CH 3 carbon atom (OA CH 3 ) and the position of the tripodal nitrogen atom (N tren ). ESI Fig. S4 .33 † demonstrates that in the middle of the POPC bilayer (z ¼ 0Å) where lipid chains are highly disordered, the OA À chain is randomly orientated.
However, as the complex moves towards the water/lipid interface the OA chain becomes aligned with the phospholipid alkyl tails. (Fig. 6C, step 12 ) aer it has promoted Cl À transport (Fig. 6, steps 2 and 3) .
However, the high energy barrier for 6$OA À to reach the interface suggests that this event is unlikely. Consequently, dissociation of the 6$OA À complex should occur just under the water/lipid interface, releasing the transporter to bind a solvated Cl À and reinitiate anion transport (Fig. 6C, step 1) . 
Conclusions
This study explored the relationship between uorination of alkyl substituents in tripodal anion transporters and their ability to transport anions across lipid bilayers and cell membranes. Fluorination increased strongly the activity of compounds with shorter alkyl tails through enhanced lipophilicity. Importantly, uorinated anionophores displayed an unusual transport mechanism because the free transporter failed to rapidly cross the membrane in vesicle-based pH discharge assays. Consistent with these data, molecular modelling revealed stronger interactions of uorinated anionophores with phospholipid bilayers than non-uorinated analogues. It also demonstrated that transport activity relies on a nely-tuned balance between lipophilicity and anion binding affinity for each transporter. However, Cl À uptake and release occurs at the water/lipid interface without transporters partitioning into the water phase, as recently found for squaramide transporters. 29 Thus, these anionophores assist Cl À translocation by a shuttling mechanism.
In conclusion, this work demonstrates that full characterisation of transport mechanisms in proton transporter-assisted vesicle assays is an important tool to improve the activity of synthetic transporters. However, care must be taken to ensure that the rate limiting step in vesicle assays corresponds to the same step in cell-based assays given the complexity of biological membranes. Using this approach, compounds with therapeutic potential will be identied.
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